Intelligence · Clinical Development
Pipeline search results
Programs matching “covid-19” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 147 pipeline programs matching "covid-19" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Convalescent Plasma
United Therapeutics Europe Ltd
COVID-19
1 trial -
CoronaVac®
Sinovac Research and Development Co.,
COVID-19
1 trial -
Dupilumab
CATALYST PHARMACEUTICALS, INC.
COVID-19
1 trial -
EDP-235
ENANTA PHARMACEUTICALS INC
COVID-19
3 trials -
FSD201
Quantum Biopharma
COVID-19
1 trial -
HB-adMSC
United Therapeutics Europe Ltd
COVID-19
1 trial -
Human COVID-19 immunoglobulin (pH4) for intravenous injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
Hydroxychloroquine (HCQ)
Teva Pharma GmbH
COVID-19
1 trial -
Ibrutinib
United Therapeutics Europe Ltd
Asymptomatic COVID-19 Infection Laboratory-Confirmed
1 trial -
JSVCT099
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
Lucinactant
WINDTREE THERAPEUTICS INC /DE/
COVID-19
1 trial -
MRx-4DP0004
4D Molecular Therapeutics
COVID-19
1 trial -
Mavrilimumab
Kiniksa Pharmaceuticals International, plc
COVID-19
3 trials -
NestaCell®
Vera Therapeutics
COVID-19 Pneumonia
1 trial -
OT-101
Oncotelic Therapeutics
COVID-19
1 trial -
PRO-nCOV-1002
Sinovac Research and Development Co.,
COVID-19
2 trials -
PRO-nCOV-1003
Sinovac Research and Development Co.,
COVID-19
1 trial -
PRO-nCOV-2002
Sinovac Research and Development Co.,
COVID-19
1 trial -
PRO-nCOV-2004
Sinovac Research and Development Co.,
COVID-19
1 trial -
PRO-nCOV-2009
Sinovac Research and Development Co.,
COVID-19
1 trial -
PUL-042 Inhalation Solution
United Therapeutics Europe Ltd
COVID-19
2 trials -
Part1:Recombinant two-component COVID-19 vaccine (CHO cell)
Jian Li
COVID-19
1 trial -
Piclidenoson
Can-Fite BioPharma
COVID-19
1 trial -
REGN10933+REGN10987 combination therapy
Regeneron UK Limited
COVID-19
2 trials
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.